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Abstract
Background: Viruses have evolved to evade the host’s complement system. The open reading frames 4 (ORF4) of
gammaherpesviruses encode homologs of regulators of complement activation (RCA) proteins, which inhibit complement
activation at the level of C3 and C4 deposition. Besides complement regulation, these proteins are involved in heparan
sulfate and glycosaminoglycan binding, and in case of MHV-68, also in viral DNA synthesis in macrophages.
Methodology/Principal Findings: Here, we made use of MHV-68 to study the role of ORF4 during infection of fibroblasts.
While attachment and penetration of virions lacking the RCA protein were not affected, we observed a delayed delivery of
the viral genome to the nucleus of infected cells. Analysis of the phosphorylation status of a variety of kinases revealed a
significant reduction in phosphorylation of the protein kinase Akt in cells infected with ORF4 mutant virus, when compared
to cells infected with wt virus. Consistent with a role of Akt activation in initial stages of infection, inhibition of Akt signaling
in wt virus infected cells resulted in a phenotype resembling the phenotype of the ORF4 mutant virus, and activation of Akt
by addition of insulin partially reversed the phenotype of the ORF4 mutant virus. Importantly, the homologous ORF4 of
KSHV was able to rescue the phenotype of the MHV-68 ORF4 mutant, indicating that ORF4 is functionally conserved and
that ORF4 of KSHV might have a similar function in infection initiation.
Conclusions/Significance: In summary, our studies demonstrate that ORF4 contributes to efficient infection by activation of
the protein kinase Akt and thus reveal a novel function of a gammaherpesvirus RCA protein.
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Introduction
Viruses use a variety of strategies to evade the host’s immune
response [1,2]. A host mechanism involved in innate immunity
against viruses is the complement system. Consequently, viruses
have evolved to evade the actions of the complement system,
thereby avoiding destruction by complement-mediated mecha-
nisms [3–6]. A number of viruses not only avoid inactivation and
destruction by complement but also use complement receptors to
initiate infection. For example, EBV infects its target cell, the B
cell, via complement receptor type 2 (CR2) [7].
The poxviral complement control protein VCP (vaccinia virus
complement control protein) can bind to complement components
C3b and C4b, respectively, thereby inactivating complement
components or blocking the formation of the C3 convertase
complex [8]. Extracellular vaccinia virus is resistant to comple-
ment because of incorporation of host complement control
proteins into its envelope [9]. Herpesviruses encode complement
regulatory proteins that can block complement activation and
neutralization of virus particles [3]. For example, HSV-1
glycoprotein gC prevents complement-mediated cell lysis and
virus neutralization [10,11]. The open reading frame 4 (ORF4) of
gammaherpesviruses, including human herpesvirus 8 (HHV-8;
KSHV), herpesvirus saimiri (HVS), murine gammaherpesvirus 68
(MHV-68) and rhesus rhadinovirus (RRV), encode homologs of
host regulators of complement activation (RCA) proteins [12–17].
MHV-68, HVS and RRV RCA proteins inhibit complement
activation at the level of C3 and C4 deposition [15,18–21]. The
KSHV complement control protein (KCP) accelerates the decay
of classical C3 convertase and induces the degradation of activated
complement factors C4b and C3b [22]. The MHV-68 RCA
protein has been shown to play an important role in viral evasion
of complement in acute, persistent and latent infection in vivo
[23].
Besides complement regulation, viral RCA proteins may have
additional functions. For example, the poxvirus B5R protein is
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11672essential for virion morphogenesis and is also involved in
polymerization of actin on virions in infected cells [24]. HSV gC
may play a role in infection by interacting with heparan sulfate or
attaching to polarized epithelial cells [25,26]. Similarly, the RCA
proteins of the gammaherpesviruses KSHV and MHV-68 have
also been shown to interact with heparan sulfate and glycosami-
noglycans [27–29]. In addition, the MHV-68 RCA protein has
very recently been shown to facilitate MHV-68 replication in
primary macrophages in a complement independent manner [30].
Studies to investigate the function of KSHV ORF4 during lytic
infection are limited by the lack of a cell culture system capable of
supporting productive replication. In contrast, MHV-68 replicates
in conventional tissue culture systems and thus provides a model to
study de novo gammaherpesvirus infection. MHV-68 is a natural
pathogen of wild rodents [31]. The nucleotide sequence of MHV-
68 is very closely related to KSHV [14]. Therefore, the functional
roles of conserved gammaherpesvirus proteins can be addressed by
mutagenesis of the corresponding viral genes [32].
Here, we made use of MHV-68 to study the role of ORF4 during
infection of fibroblasts. While attachment and penetration of virions
lacking the RCA protein were not affected, we observed a delayed
delivery of the viral genome to the nucleus of infected cells,
consistent with our previously published findings (30) that deletion
of ORF4 results in delayed replication of MHV-68 in fibroblasts.
Analysis of the phosphorylation status of a variety of kinases in
infected cells revealed a significant reduction in the phosphorylation
of the protein kinase Akt in cells infected with ORF4 mutant virus,
whencomparedtocellsinfected withwtvirus.Consistent witharole
of Akt activation in the initial stage of the infection, inhibition of Akt
signalingbythespecific inhibitor Triciribineincells infected with wt
virus resulted in a phenotype closely resembling the phenotype of
the ORF4 mutant virus. Pre-activation of Akt by addition of insulin
partially reversed the phenotype of the ORF4 mutant virus.
Importantly, the homologous ORF4 of KSHV was able to rescue
the phenotype of the MHV-68 ORF4 mutant, indicating that
ORF4 is functionally conserved and that ORF4 of KSHV might
have a similar function in infection initiation.
Results
Delayed infection kinetics of ORF4 mutants as
determined by FACS analysis and quantitative RT-PCR
We had previously reported that the ORF4
2Tet
+ mutant
showed delayed growth in fibroblasts in cell culture when
compared to the parental virus [32]. Importantly, the correspond-
ing ORF4 revertant displayed wt growth properties, indicating
that the delayed growth of the ORF4
2Tet
+ mutant was due to
deletion of ORF4 and not due to rearrangements outside ORF4
[32]. Now, we report on experiments aimed to discover the
underlying mechanism(s). We hypothesized that one reason for the
delayed growth might be that mutation of ORF4 affects initial
stages of infection. To investigate this in more detail, we made use
of expression of the green fluorescent protein (gfp), an inherent
property of the recombinant viruses used [32]. The gfp is driven
by the HCMV ie promoter and thus, its expression is independent
of the replication of the viral genome and starts once the viral
genome has reached the nucleus. NIH3T3 cells were infected with
parental virus, ORF4
2Tet
+ mutant and ORF4 revertant at a
multiplicity of infection of 10 for 1h at 37uC. Then, the inoculum
was removed and fresh medium, with or without PAA, which
inhibits DNA synthesis, was added. Cells were harvested
immediately thereafter or after 6, 18 and 48 hours, and analyzed
for gfp expression by FACS analysis. As expected, cells harvested
immediately after infection were negative for gfp, indicating that
gfp was not directly delivered to the infected cells by input virus
but that gfp expression starts only after the viral genome has
reached the nucleus (data not shown). After infection with the
ORF4
2Tet
+ mutant, the increase in the number of gfp-positive
cells was significantly delayed, when compared to the infection
with parental virus or ORF4 revertant (Fig. 1A). The reduction
Figure 1. Kinetics of gfp-expression after infection of NIH3T3 cells with parental virus, the deletion mutant ORF4
2Tet
+ or the ORF4
revertant. Cells were infected at a multiplicity of infection of 10 for 1h at 37uC. Then, the inoculum was removed and fresh medium, without (panel
A) or with (panel B) phosphonoacetic acid (PAA), was added. Cells were harvested immediately thereafter and after 6, 18 and 48 hours, respectively,
and analyzed for gfp expression by FACS analysis. Data shown are means 6 SD of three independent experiments. The asterisks indicate that the
expression of gfp is significantly delayed after infection with the ORF4
2Tet
+ mutant, when compared to parental or revertant virus (p,0,02; Two-way
ANOVA).
doi:10.1371/journal.pone.0011672.g001
ORF4 of MHV-68
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growth kinetics described previously [32]. To further support our
hypothesis that mutation of ORF4 might affect an initial stage of
infection and thus is independent from virus replication, we
performed the same experiments in the presence of PAA. As
shown in Fig. 1B, the results were very similar to those obtained in
the absence of PAA. The reduced number of gfp-positive cells after
infection with the ORF4
2Tet
+ mutant was not specific for
NIH3T3 cells since it was also observed in mouse embryonic
fibroblasts (MEF) (Fig. S1). Furthermore, it was not due to the
presence of the tetracycline resistance gene in the mutant
ORF4
2Tet
+, because mutant ORF4
2Tet
2, in which the
tetracycline resistance gene has been removed, showed the same
phenotype (Fig. S1).
To exclude the possibility that protein translation and thus gfp-
expression is not equivalent between ORF4
2Tet
+ mutant and
parental or ORF4 revertant virus, we investigated the infection
kinetics of the ORF4 mutant at the mRNA level by quantitative
real-time RT-PCR. For this purpose, we examined the expression
of the message of the MHV-68 immediate-early gene Rta
(ORF50) [33] which can only be transcribed after the viral
genome has reached the nucleus. 18 hours after infection, the
amount of detectable ORF50 mRNA was significantly lower in
cells infected with the ORF4
2Tet
+ mutant, when compared to the
parental or to the corresponding revertant virus (Fig. 2). In
addition, an independently constructed ORF4.STOP virus
showed a similar phenotype. Taken together, the RT-PCR data
are consistent with the results from the FACS analysis, and both
are indicative for a delayed delivery of the virus genome to the
nucleus of the infected cell. We concluded from these data that the
similarity of the phenotype of two ORF4 mutant viruses
constructed independently is strongly suggestive for the phenotype
being due to mutation of ORF4.
To further support this hypothesis and to exclude the possibility
that mutation of ORF4 affected the transcription of neighbouring
genes, we analyzed their transcription by quantitative real-time
RT-PCR. As shown in Fig. S2A, mutations introduced into ORF4
did not change transcript levels from the adjacent genes M4 and
ORF6.
Attachment and penetration of ORF4 mutants
The experiments thus far supported our hypothesis that the
mutation of ORF4 most likely affects an initial step of the infection
process and not a late step which occurs after the viral genome has
reached the nucleus and which requires DNA replication. Initial steps
of herpesvirus infection include attachment, penetration, uncoating,
transport of the capsids to and release of the viral genome into the
nucleus [34]. Therefore, we next performed experiments analyzing
attachment and penetration by different methods as described in
experimental procedures. For both processes, we could not detect
appreciable differences between ORF4
2Tet
+,p a r e n t a lv i r u sa n d
ORF4 revertant (Table S1 and Fig. S3).
Figure 2. Delayed infection kinetics of the ORF4
2Tet
+ and ORF4.STOP mutants as determined by quantitative RT-PCR. The expression
of the mRNA of the MHV-68 immediate-early gene Rta (ORF50) was examined by quantitative RT-PCR. Cells were infected at a multiplicity of infection
of 10 for 1h at 37uC. Then, the inoculum was removed and fresh medium with PAA was added. Total RNA was isolated from infected cells 18 hours
after infection and reverse transcribed. The resulting cDNA was used as template for PCR amplification of L8 and MHV-68 ORF50, respectively. Data
are presented as relative expression of ORF50 after normalization to the corresponding L8 levels using the delta-delta Ct method. 18 hours after
infection, the expression of the ORF50 mRNA was significantly reduced (*, p=0,002; **, p=0,025; Student’s t-test) in cells infected with the ORF4
mutants when compared with the parental or revertant virus. Data shown are means 6 SD of two independent experiments, each determined in
duplicates.
doi:10.1371/journal.pone.0011672.g002
ORF4 of MHV-68
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2Tet
+ and
ORF4.STOP mutants as determined by fluorescence
microscopy
Since attachment and penetration of ORF4 mutant viruses were
not affected, we wanted to investigate the fate of the viruses in the
subsequent phase of infection. For this purpose, we visualized virus
particles immediately after adsorption and 3h post infection by
staining with a polyclonal rabbit anti-MHV-68 antiserum and
fluorescence microscopy. Immediately after adsorption, compara-
ble numbers of equally distributed parental, revertant and ORF4
mutant virus particles were observed (Fig. 3, 0h). After 3h,
however, parental and revertant virus particles accumulated
around the nucleus of infected cells (Fig. 3, 3h). In contrast, both
the ORF4
2Tet
+ and ORF4.STOP mutant virus particles
appeared mainly localized in the periphery. At 8h post infection,
newly synthesized viral proteins were already recognized by the
anti-MHV-68 antiserum in cells infected with parental and
revertant virus, respectively (Fig. 3, 8h). On the contrary, at this
time, ORF4
2Tet
+ and ORF4.STOP mutant virus particles were
now detectable around the nucleus, almost like parental and
revertant viruses were at 3h post infection. In addition, de novo
synthesis of viral proteins appeared just to be at the beginning, also
indicative of a delayed infection kinetics. We concluded from these
data that viruses lacking the RCA protein are less efficient in their
ability to accumulate around the nucleus of infected cells.
Determination of the phosphorylation status of key
cellular kinases
Infection of target cells by viruses is accompanied by virus-
induced signaling events which create an appropriate intracellular
environment to facilitate infection [35]. Thus, we set up
experiments analyzing the phosphorylation status of a variety of
serine/threonine kinases in infected cells. To this end, we
simultaneously analyzed the relative phosphorylation of 14 kinases
in NIH3T3 cells infected with parental virus or the mutant virus
ORF4
2Tet
+ using the R&D Proteome ProfilerH MAPK Array
Kit. The results revealed phosphorylation of ERK1 and ERK2
after infection with either virus. In contrast, p38c and particularly
Akt (i.e., Akt1, Akt2 and Aktpan, but not Akt3) appeared strongly
phosphorylated after infection with parental virus but only weakly
Figure 3. Delayed infection kinetics of the ORF4
2Tet
+ and ORF4.STOP mutants as determined by fluorescence microscopy. For
immunofluorescence staining, NIH3T3 cells were seeded on coverslips in 12 well plates the day before staining. Cells were infected at a multiplicity of
infection of 5–10 for 1h at 4uC to allow adsorption. Then, cells were washed three times and were either immediately (0h – upper panel) fixed with 4%
paraformaldehyde or prewarmed medium was added and the cells were further incubated at 37uC. Three hours later (3h – median panel) or eight
hours later (8h – lower panel), cells were fixed and permeabilized with 0.1% Triton-X100. Virus particles were visualized with polyclonal rabbit anti-
MHV-68 antiserum followed by goat anti-rabbitCy3 antibody. Stained cells were mounted in ProLongH Gold antifade reagent with DAPI and analysed
by using a Zeiss Axiovert 200M microscope. Cells were viewed with a 1006oil immersion objective. The top panel shows staining of uninfected cells
as control. One representative experiment of 5 is shown.
doi:10.1371/journal.pone.0011672.g003
ORF4 of MHV-68
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2Tet
+ (data not shown). Subsequently,
we analyzed this in more detail applying cell-based protein
phosphorylation ELISAs. While the initially observed difference in
the phosphorylation of p38c could not be verified in these
subsequent experiments (data not shown), the difference in
phosphorylation of Akt was consistently observed (Fig. 4A).
Infection with both the ORF4
2Tet
+ mutant and the ORF4
revertant resulted in phosphorylation of Akt at 30 min after
infection. However, while the level of phosphorylation continu-
ously increased until 18 h after infection with the ORF4 revertant,
the increase in the phosphorylation level was significantly delayed
after infection with the ORF4
2Tet
+ mutant. Importantly, there
was no difference in total Akt levels during the time course of the
experiment (Fig. 4B). The decrease in total Akt levels (with both
viruses) at later time points most likely reflects the reduction in
overall cellular protein synthesis, indicative of host shutoff, as it has
recently been published [36].
Inhibition of Akt phosphorylation/activation by
treatment with Triciribine
These data suggested that activation of Akt is obviously
important for the effective initiation of the infection. To support
this hypothesis, we applied the well described specific inhibitor of
Akt signaling Triciribine (TCN) [37]. Consistent with a role of Akt
activation in the initial stage of infection, inhibition of Akt
signaling by treatment of parental virus-infected cells with TCN
resulted in a dose-dependent effect closely resembling the
phenotype of the ORF4 mutant virus, as determined by FACS
analysis and microscopy (Fig. 5A and B).
Phosphorylation of Akt by insulin reverses the phenotype
of the ORF4 mutant ORF4
2Tet
+
We hypothesized that, if the initial signaling event is important,
activation of Akt should reverse the phenotype of the ORF4
mutation. First, NIH3T3 cells were treated with insulin for 30 or
60 min, harvested and analyzed by Western blotting using anti-
phospho-Akt antibody and anti-total-Akt antibody, respectively.
As described [38], insulin readily induced phosphorylation of Akt
(Fig. 6A). Second, we analyzed the effect of insulin treatment on
viral infection. NIH3T3 cells were treated with insulin starting
60 min prior to infection. Then, insulin was washed away, and
cells were infected at a multiplicity of infection of 5–10. After 1h at
37uC, the inoculum was removed and fresh medium was added.
Cells were harvested after 18 hours and analyzed for gfp
expression. As shown in Fig. 6B, treatment of the cells with
insulin resulted in a significant, but not complete, reversion of the
phenotype of the ORF4
2Tet
+ mutant.
Complementation by ORF4 of KSHV
To test whether ORF4 of KSHV can rescue the phenotype of
an ORF4 deletion mutant, a recombinant MHV-68 expressing
ORF4 of KSHV was constructed. For this purpose, ORF4 of
KSHV was inserted in the mutant ORF4
2Tet
+. The insertion of
ORF4 of KSHV did not change transcription levels of adjacent
genes M1 and M2 (Fig. S2B). Cells were infected with parental
virus, ORF4
2Tet
+ mutant virus and ORF4
2Tet
+ mutant virus
expressing ORF4 of KSHV at a multiplicity of infection of 10 for
1h at 37uC. Then, the inocula were removed and fresh medium,
containing phosphonoacetic acid (PAA), was added. Cells were
harvested 18 hours after infection and analyzed for gfp expression
by FACS analysis. As before, the number of gfp-positive cells after
infection with the ORF4
2Tet
+ mutant was significantly reduced
when compared to the infection with parental virus while
expression of ORF4 of KSHV rescued the phenotype of the
MHV-68 ORF4 deletion mutant ORF4
2Tet
+ (Fig. 7).
Discussion
Previously, it had been shown that the MHV-68 RCA protein
inhibits complement activation at the level of C3 [18]. It plays an
important role in viral evasion from complement in acute,
Figure 4. The relative phosphorylation level of the protein kinase Akt is significantly reduced after infection with the deletion
mutant ORF4
2Tet
+. Cells were infected at a multiplicity of infection of 10 or left uninfected (=time point 0). At the indicated time points after
infection, the relative phosphorylation levels of the protein kinase Akt were determined by a cell-based protein phosphorylation ELISA. The data are
presented as the amount of activated (phosphorylated) Akt protein (pAkt) relative to total Akt protein (tAkt) (panel A). Total Akt levels are additionally
depicted in panel B. Data shown are means 6 sem of three to seven independent determinations, each performed in triplicate. The asterisks indicate
that the difference between ORF4
2Tet
+ and ORF4 revertant is statistically significant (p,0,05; Two-way ANOVA).
doi:10.1371/journal.pone.0011672.g004
ORF4 of MHV-68
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shown to be the major glycosaminoglycan (GAG)-binding protein
of MHV-68 [29], promoting the initial contact of virions to
cellular GAGs [39]. Recently, it has also been shown to facilitate
replication in macrophages in a complement independent manner,
being required for efficient DNA synthesis [30]. Here, we
elucidated a new function of the MHV-68 RCA protein, encoded
by ORF4. While, as reported by others [40], attachment and
penetration of virions lacking the RCA protein were not affected,
the entry of the virus genome into the nucleus of the infected cell
was slowed down by mutation of ORF4. This finding explains our
previously reported observation of delayed growth of the
ORF4
2Tet
+ mutant in fibroblasts in cell culture [32]. In contrast
to our findings, another group did not observe the delayed growth
Figure 5. Inhibition of Akt activation in cells infected with parental virus leads to a phenotype closely resembling the phenotype of
the ORF4 mutant virus. NIH3T3 cells were treated with the indicated doses of Triciribine (TCN), or as a control, with DMSO, starting 1 h prior to
infection. Then, cells were infected at a multiplicity of infection of 5–10. After 1h at 37uC, the inoculum was removed and fresh medium, with TCN or
DMSO, respectively, was added. Cells were harvested after 18 hours and analyzed for gfp expression by FACS analysis (panel A), or were analyzed
after 1.5 hours by microscopy using a 1006oil immersion objective (panel B) as described in Figure 3. Data shown in panel A are means 6 SD of four
independent experiments. The asterisk indicates a statistically significant difference of p=0,005, and the two asterisks indicate a statistically
significant difference of p=0,0003 (Student’s t-test). In panel B, one representative experiment of 2 is shown.
doi:10.1371/journal.pone.0011672.g005
Figure 6. Phosphorylation of Akt by insulin reverses the phenotype of the MHV-68 ORF4 deletion mutant ORF4
2Tet
+. A) The
expression of total Akt (tAkt) and its phosphorylated form (pAkt) was analyzed in insulin-treated NIH3T3 cells by Western blotting. The cells were
treated with 10 mg/ml insulin for various time periods (min) as indicated. pAkt (upper panel) was detected with anti-phospho-Akt antibody (#9271),
and tAkt (lower panel) was detected with anti-total-Akt antibody (#9272), both from Cell Signaling Technology (Danvers, MA). B) NIH3T3 cells were
treated with insulin starting 60 min prior to infection. Then, insulin was washed away, and cells were infected at a multiplicity of infection of 5–10.
After 1h at 37uC, the inoculum was removed and fresh medium was added. Cells were harvested after 18 hours and analyzed for gfp expression by
FACS analysis. Treatment of the cells with insulin resulted in a significant reversion of the phenotype of the ORF4
2Tet
+ mutant (p=0,037; Student’s t-
test). Data shown are means 6 SD of at least three independent experiments.
doi:10.1371/journal.pone.0011672.g006
ORF4 of MHV-68
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assume that this might be due to a different basal Akt activation
status of the cells used and/or to the different infection protocols.
As described [32], we infected the cells for 1h at 4uC to allow
adsorption. For penetration, prewarmed medium was then added
for a 2h incubation period at 37uC. Finally, remaining
extracellular virus was inactivated by low pH-treatment with
citrate buffer for 1min. Thus, the infection is highly synchronized
and remaining input virus is more vigorously removed than after
standard infection procedures which may allow to uncover
differences at very early steps of infection. In our assays (Fig. 2
and 3), the ORF4.STOP mutant showed a phenotype very similar
to the phenotype of the ORF4
2Tet
+ mutant. Analysis of the
phosphorylation status of a variety of kinases in infected cells
revealed a significant reduction in the phosphorylation of the
protein kinase Akt in cells infected with ORF4 mutant virus.
Consistent with a role of Akt activation in the initial stages of
infection, inhibition of Akt signaling resulted in a similar
phenotype as observed for the ORF4 mutant virus. Vice versa,
activation of Akt by insulin reversed the phenotype of the ORF4
mutant to a significant extent. Interestingly, it had been speculated
earlier that the MHV-68 RCA protein might function through
induction of intracellular signals [18]. The homologous ORF4 of
KSHV was able to rescue the phenotype of the MHV-68 ORF4
mutant, indicating that ORF4 is functionally conserved and that
ORF4 of KSHV might have a similar function in infection
initiation. The RCA proteins of MHV-68 and of KSHV are virion
constituents [28,29]. Thus, it is conceivable that they can trigger
signal transduction cascades which might facilitate productive
infection. Consistent with our data, it has recently been shown that
MHV-68 infection of NIH3T3 cells activates Akt [41]. Although it
was postulated that early Akt activation possibly correlated with
viral binding and entry, the authors did not observe a significant
effect of the PI3K inhibitor LY294002 on early steps of the viral
life cycle. In our hands, treatment of cells with the Akt inhibitor
TCN resulted in a delayed delivery of the viral genome to the
nucleus of infected cells. In addition, ORF4 mutant viruses with a
reduced capacity to activate Akt showed the same phenotype, and
activation of Akt by insulin was able to release this phenotype to a
significant extent, thus providing further evidence for a role of Akt
activation in promoting infection. For KSHV, it has been shown
that the appropriate intracellular environment to facilitate
infection is created by the induction of various signaling cascades:
KSHV can induce the PI3-kinase-PKC-j-MEK-ERK signaling
pathway early during infection [42,43]. It also induces the
integrin-dependent focal adhesion kinase-Src-PI3-kinase-Rho-
GTPase signaling pathway by its glycoprotein gB [44–46]. In
addition, KSHV also activates the JNK and p38 mitogen-activated
protein kinase (MAPK) pathways during primary infection [47].
Many of these signaling events have been shown to be important
for post-binding virus entry steps, for example modulation of
microtubules, movement of virus in the cytoplasm and nuclear
delivery of viral DNA [48]. The K1 protein of KSHV activates the
Akt signaling pathway in B lymphocytes and it was suggested that
it thereby promotes cell survival and prevents apoptosis of infected
cells [49]. Many viruses and viral proteins affect the PI3-kinase-
Akt signaling pathway, and this has mainly been associated with its
fundamental role in the regulation of apoptosis and cellular
survival [50]. However, besides its central role in regulation of
apoptosis, the PI3-kinase-Akt signaling pathway is also involved in
the regulation of numerous cellular functions as diverse as cell
metabolism, cell polarity and membrane and vesicular trafficking
[51,52]. Thus, activation of this pathway may be exploited by
viruses in multiple ways beyond the regulation of apoptosis.
Indeed, human cytomegalovirus up-regulates the PI3-kinase
pathway to initiate viral DNA replication and to complete the
lytic life cycle [53]. Importantly, similar to our data, it has recently
been shown that the PI3-kinase-Akt pathway controls cellular
Figure 7. ORF4 of KSHV rescues the phenotype of the MHV-68 ORF4 deletion mutant ORF4
2Tet
+. Cells were infected at a multiplicity of
infection of 10 for 1h at 37uC. Then, the inoculum was removed and fresh medium, containing phosphonoacetic acid (PAA), was added. Cells were
harvested 18 hours after infection and analyzed for gfp expression by FACS analysis. Data shown are means 6 SD of three independent experiments.
The asterisk indicates that the number of gfp-positive cells after infection with the ORF4
2Tet
+ mutant was significantly reduced when compared to
parental virus or ORF4
2Tet
+ with KSHV-ORF4 (p,0,05; Student’s t-test).
doi:10.1371/journal.pone.0011672.g007
ORF4 of MHV-68
PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11672entry of Ebola virus [54]. Inhibition of PI3-kinase or Akt caused an
aberrant accumulation of Ebola virus particles in intracellular
vesicles, indicating a role of the PI3-kinase-Akt pathway in
vesicular trafficking of virus particles [54]. Entry of KSHV and
MHV-68 into fibroblasts or epithelial cells occurs via endocytosis
[55–57]. Endocytosed viruses then penetrate the endosomal
membrane by fusion of the viral envelope with the membrane of
the endocytic vesicle to be released into the cytoplasm [35]. Thus,
we hypothesize that virus lacking the RCA protein is less efficient
in its ability to leave endocytic vesicles. Our current working
hypothesis (Fig. 8) is that both wt and ORF4 mutant virus initially
activate – in an ORF4-independent manner - the Akt pathway.
After being endocytosed, the wt virus is able to maintain the
activation of Akt in an ORF4-dependent manner which aids to
control endocytic movement and/or to leave the endosome rather
quickly. In contrast, the ORF4 mutant virus is trapped much
longer in the endosome and escapes with delay, most likely by
additional, ORF4-independent mechanisms. Since the RCA
protein encoded by ORF4 is incorporated into mature viral
particles via interactions with other virion components, it might
also be possible that mutation of ORF4 additionally affects other
viral proteins which could also contribute to the observed effects. It
is well known that viruses may alter cellular signaling pathways, in
particular PI3-kinase, to control their endocytic movement [35].
For example, endocytosis of adeno-associated virus type 2 occurs
through activation of Rac1 and PI3-kinase which directs virus
movement along the cytoskeleton to the nucleus [58]. In addition,
inhibition of adenovirus type 2-mediated signaling via protein
kinase C has been shown to prevent escape of adenovirus from
endosomes, resulting in an accumulation in cytoplasmic vesicles
near the cell periphery [59]. It is also known that endocytic vesicles
can function as a signaling compartment distinct from the plasma
membrane [60]. Signaling from endosomes allows spatial and
temporal regulation of signal transduction, and the transmitted
signals may be qualitatively different from those initiated at the
plasma membrane [60,61]. We hypothesize that this is the reason
why activation of Akt by insulin did not completely reverse the
phenotype of the ORF4 mutant. Addition of insulin to the cell
culture can certainly not completely mimic signaling from
endosomes. The KSHV-K1 protein continues to transduce Akt-
activating signals from an intracellular compartment after
internalization through clathrin-mediated endocytosis [62], pro-
viding a paradigm for a gammaherpesviral protein which signals
from endocytic vesicles. Since Akt is known to be associated with
certain vesicles [63], it is plausible that viral proteins may activate
Akt from intracellular compartments.
In summary, our studies demonstrate the ORF4 contributes to
an efficient de novo infection process and thus reveal a novel
function of a gammaherpesvirus RCA protein. This novel function
might also contribute, besides the already known functions
described above, to the lytic replication deficit which has been
observed in vivo after intracerebral and intraperitoneal [23] or
intranasal [40] infection of mice with ORF4 mutant viruses.
Notably, in a meningoencephalitis model of acute MHV-68
infection of weanling mice, the MHV-68 RCA protein was
observed to play a key role in the invasion of brain parenchymal
cells [23]. It was also observed that the MHV-68 RCA protein was
particularly present in the cytoplasm and plasmalemma of infected
CNS cells, however, the potential physiologic role of cytoplasmic
MHV-68 RCA protein remained unclear. It is tempting to
speculate that in this model, the Akt-activating function described
here may have contributed to the observed phenotype. It may thus
provide a rationale for the observation of Kapadia et al. that the
most significant attenuation caused by the loss of the MHV-68
RCA protein was observed in the CNS, an organ where
complement levels are actually considered to be rather low [23].
Materials and Methods
Cell culture, virus stocks and plaque assays
Cell culture, virus stocks and plaque assays were performed
essentially as described [32].
Generation of recombinant viruses
The construction of the mutants ORF4
2Tet
+ and ORF4
2Tet
2
and of the corresponding revertant (ORF4 revertant) has already
been described [32]. To test whether ORF4 of KSHV can rescue
the phenotype of the mutant ORF4
2Tet
+, ORF4 of KSHV was
Figure 8. Current model/Working hypothesis. Both wildtype virus (wt; black) and ORF4 mutant virus (DORF4; grey) initially activate – in an
ORF4-independent manner – the Akt pathway (a). After being endocytosed, the wt virus is able to maintain the activation of Akt in an ORF4-
dependent manner which aids to leave the endosome rather quickly (b). In contrast, due to the lack of ORF4, ORF4 mutant virus is trapped much
longer in the endosome and escapes with delay, most likely by additional, ORF4-independent mechanisms (c).
doi:10.1371/journal.pone.0011672.g008
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2Tet
+. For this purpose, ORF4 of
KSHV (kindly provided by Dr. J. Haas, Max von Pettenkofer-
Institute, Munich, Germany) was cloned into the plasmid
pMCMV4 (kindly provided by Dr. M. Messerle, Hannover
Medical School, Hannover, Germany) between the MCMV
promoter and polyA signal. The expression cassette (excised by
HindIII) was cloned blunt end into the BglII site (position 3846 of
the MHV-68 genome) of the plasmid pST76K-SR containing a
3.9 kb fragment of MHV-68 (nucleotide positions 2406–6261).
The resulting shuttle plasmid was used for mutagenesis by the two-
step replacement procedure as described [64,65]. For comparison,
we additionally tested an independently constructed ORF4 mutant
(ORF4.STOP) [23], kindly provided by Dr. H.W. Virgin
(Washington University, MO), containing a translational stop in
ORF4 which eliminates expression of the MHV-68 RCA protein.
FACS Analysis
NIH3T3 cells (ATCC CRL 1658) were infected at a multiplicity
of infection of 10 for 1h at 37uC. Then, the inoculum was removed
and fresh medium, with or without phosphonoacetic acid (PAA),
was added. PAA, an inhibitor of DNA synthesis, was used at a final
concentration of 250 mg/ml. Cells were harvested immediately
thereafter and after 6, 18 and 48 hours, respectively, centrifuged
and resuspended in 0.5% to 2% paraformaldehyde in PBS.
Usually, 5000–10000 cells were collected on a FACSCalibur
(Becton Dickinson, Heidelberg, Germany) and analyzed for gfp
expression. Data analysis was performed using CellQuest
TM
software (Becton Dickinson).
RNA-isolation and RT-PCR
Total RNA was isolated from infected cells using the RNeasyH
Mini Kit (Qiagen GmbH, Hilden, Germany), followed by an
additional DNAse treatment using the TURBO DNA-free
TM Kit
(Applied Biosystems, Darmstadt, Germany), according to the
instructions of the manufacturers. 500 ng RNA was reverse
transcribed using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems) according to the instructions of the
manufacturer or subjected to mock reverse transcription in the
absence of the enzyme (-RT control). 5 ml of the resulting cDNA
were used as template for PCR amplification with the ABI 7300
Real Time PCR System, using Power SYBRH Green PCR Master
Mix and universal cycling conditions (Applied Biosystems). Ct
values of -RT controls did not exceed background levels. The
following MHV-68 gene specific primers were used:
ORF50 forward: 59-CCCACGGTTCGCTATACAGTAAA-
GAC-39
ORF50 reverse: 59-ATTGTGTAGAGGGTCCAGGTTAAT-
GATTTC-39
M1 forward: 59-ATCTCACCTTTGCTGGATTCTTATTT-
GC-39
M1 reverse: 59-GTTCTGATGGCTTGAAACGATGGC-39
M2 forward: 59-TCCTCGCCCCACTCCACAAAAC-39
M2 reverse: 59-AACACCCCATGAACCCTGAGATACG-39
M4 forward: 59-CCTCGGCATGGGATAACTATACTTC-
TG-39
M4 reverse: 59-GCTGTGTGGCATTTGAACCTCTTG-39
ORF6 forward: 59-TTCAATGTCAAGGCACCGTGTCAG-39
ORF6 reverse: 59-CTTGTTACTGTTGTGAAAGACGATG-
GC-39.
As a housekeeping gene, the murine ribosomal protein L8 gene
(rpl8) was amplified in parallel using the following primers:
L8 forward: 59-CAGTGAATATCGGCAATGTTTTG-39
L8 reverse: 59-TTCACTCGAGTCTTCTTGGTCTC-39.
Assays for virus attachment and penetration
Attachment of viruses to NIH3T3 cells was assessed by two
different methods: i) Virus suspensions were incubated with
NIH3T3 cells for one hour at 37uC. Then, the cells were pelleted
by centrifugation, and the supernatant was collected. Afterwards,
the amount of virus in the original suspension (before incubation
with cells) as well as in the supernatant (after incubation with cells)
was determined by plaque assay. The reduction of the virus titer
was taken as the amount of attached virus. ii) Direct binding assays
using radiolabeled virus were performed as described by others
[66–68]. Viruses were labeled by generating virus stocks in the
presence of
3H-thymidine. Cells were incubated with comparable
amounts of radiolabeled viruses for 2 hours at 4uC, extensively
washed three times with ice-cold PBS at 4uC to remove unbound
viruses, harvested and lysed in 1% SDS. The cell-associated
radioactivity of the lysates was determined by counting in a
scintillation counter. The cell-associated radioactivity in percent of
the input (as determined by counting the radioactivity of the input
virus) was taken as the amount of attached virus.
For the determination of the penetration kinetics of the various
viruses, two different methods which have been described by
others [67,69] were applied: i) NIH3T3 cells were incubated with
virus for one hour at 4uC to allow adsorption. The inoculum was
then removed, and prewarmed medium was added at 37uCt o
allow penetration. Immediately thereafter and after 5, 10, 30, 60,
240 and 480 min, remaining extracellular virus was inactivated by
low-pH treatment with citrate buffer for 1min. Cells were washed
with PBS and fresh medium containing 1.5% carboxymethylcel-
lulose was added. Cells were stained after 4 to 5 days with 0.1%
crystal violet solution to determine the number of plaques. Plaques
were counted, and the percentage of PFU surviving low-pH
treatment, compared to a PBS-treated control, was calculated. ii)
NIH3T3 cells were incubated with radiolabeled virus as described
above for one hour at 4uC to allow adsorption. The inoculum was
then removed, and prewarmed medium was added at 37uCt o
allow penetration. Immediately thereafter and after 1, 4 and
8 hours, remaining extracellular virus was removed by extensive
treatment with trypsin. Cells were washed twice with PBS and the
radioactivity of the lysates, reflecting the fraction of internalized
virus, was determined by counting in a scintillation counter. The
percentage of trypsin-resistant, i.e. internalized virus, compared to
a PBS-treated control, was calculated.
Assays for the determination of kinase phosphorylation
For an initial screen of the phosphorylation status of a variety of
serine/threonine kinases in infected cells, we used the R&D
Proteome ProfilerH MAPK Array Kit (R&D Systems, Wiesbaden,
Germany). This Kit allows the simultaneous analysis of the relative
phosphorylation of 14 kinases in murine cells (ERK1 and 2, JNK1
and 2, MSK2, RSK2, p38a, c and d, GSK-3a/b and GSK-3b,
Akt1, 2 and 3) and was used according to the instructions of the
manufacturer. After the initial screening, selected kinases were
analyzed in more detail using cell-based protein phosphorylation
ELISA Kits (Cellular Activation of Signaling ELISA [CASE
TM
Kit]) (SuperArray Bioscience Corporation, Frederick, MD)
according to the instructions of the manufacturer.
Inhibition of Akt signaling
For the inhibition of Akt signaling, we used the well described
inhibitor Triciribine (TCN) which inhibits Akt signaling in a very
selective fashion [37]. TCN (Biaffin GmbH, Kassel, Germany) was
dissolved in DMSO to prepare a 3 mM stocksolution and was
used in final concentrations of 1 and 5 mM. NIH3T3 cells were
treated with TCN, or as a control, with DMSO, starting 1 h prior
ORF4 of MHV-68
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of 5–10. After 1h at 37uC, the inoculum was removed and fresh
medium, with TCN or DMSO, respectively, was added. Cells
were harvested after 18 hours, centrifuged, resuspended in 0.5%
to 2% paraformaldehyde in PBS and analyzed for gfp expression
as described above.
Activation of Akt signaling by treatment with insulin
To activate Akt signaling, we used insulin (SIGMA, Tauf-
kirchen, Germany) at a final concentration of 10 mg/ml which had
been shown to activate Akt in NIH3T3 cells [38]. First, to
demonstrate phosphorylation of Akt in NIH3T3 cells by insulin,
cells were treated for 30 or 60 min, harvested and analyzed by
Western blotting using anti-phospho-Akt antibody (#9271) and
anti-total-Akt antibody (#9272), respectively (Cell Signaling
Technology, Inc., Danvers, MA). Second, to analyze the effect
of insulin treatment on viral infection, NIH3T3 cells were treated
with insulin starting 60 min prior to infection. Then, insulin was
washed away, and cells were infected at a multiplicity of infection
of 5–10. After 1h at 37uC, the inoculum was removed and fresh
medium was added. Cells were harvested after 18 hours,
centrifuged, resuspended in 0.5% to 2% paraformaldehyde in
PBS and analyzed for gfp expression as described above.
Immunofluorescence staining of infected cells
For immunofluorescence staining, NIH3T3 cells were seeded
on coverslips in 12 well plates the day before staining. Cells were
infected at a multiplicity of infection of 5–10 for 1h at 4uC to allow
adsorption. Then, cells were washed three times, prewarmed
medium was added and the cells were incubated at 37uC. At the
indicated time points, cells were fixed with 4% paraformaldehyde
and permeabilized with 0.1% Triton-X100. Virus particles were
visualized with polyclonal rabbit anti-MHV-68 antiserum followed
by goat anti-rabbitCy3 antibody (Chemicon, Hofheim, Germany).
Stained cells were mounted in ProLongH Gold antifade reagent
with DAPI (Molecular Probes Inc., Eugene, OR) and analysed by
using a Zeiss Axiovert 200M microscope.
Supporting Information
Table S1 Deletion of ORF4 does not influence attachment.
Found at: doi:10.1371/journal.pone.0011672.s001 (0.05 MB
DOC)
Figure S1 The phenotype of ORF4 deletion mutants is not cell
type specific. NIH3T3 or C57BL/6 mouse embryonic fibroblasts
(MEF) (ATCC SCRC-1008) were infected at a multiplicity of
infection of 10 for 1h at 37uC. Then, the inoculum was removed
and fresh medium was added. Cells were harvested 18 hours after
infection and analyzed for gfp expression by FACS analysis. For
better comparison, the number of gfp-positive cells after infection
with the revertant virus was set to 100%. Data shown are means
+/2 SD of three independent experiments. The asterisks indicate
that the number of gfp-positive cells after infection with the ORF4
deletion mutants was significantly reduced when compared to
revertant virus (p,0,0005; Student’s t-test).
Found at: doi:10.1371/journal.pone.0011672.s002 (0.12 MB
TIF)
Figure S2 Quantitative RT-PCR analysis of M4 and ORF 6
(panel A) and M1 and M2 (panel B) transcription in NIH3T3 cells
infected with the indicated viruses. Shown are means +/2 SD of
three independent experiments. L8 transcription was analyzed in
parallel as a control.
Found at: doi:10.1371/journal.pone.0011672.s003 (0.17 MB
TIF)
Figure S3 Determination of penetration kinetics. NIH3T3 cells
were incubated with virus for one hour at 4uC to allow adsorption.
The inoculum was then removed, and prewarmed medium was
added at 37uC to allow penetration. Immediately thereafter and
after 5, 10, 30, 60, 240 and 480 min, remaining extracellular virus
was inactivated by low-pH treatment with citrate buffer for 1min.
Cells were washed with PBS and fresh medium containing 1.5%
carboxymethylcellulose was added. Cells were stained after 4 to 5
days with 0.1% crystal violet solution to determine the number of
plaques. Plaques were counted, and the percentage of PFU
surviving low-pH treatment, compared to a PBS-treated control,
was calculated. Data shown are means +/2 sem from two
independent experiments. No significant differences were observed
between parental virus, ORF4-Tet+ and ORF4 revertant.
Found at: doi:10.1371/journal.pone.0011672.s004 (0.11 MB
TIF)
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